Estrogen receptor profiles: changes in mouse and rat mammary tumors by treatment with selective estrogen receptor modifiers
Medical Principles and Practice. 2004; 13 (4): 220-226
em Inglês
| IMEMR
| ID: emr-67715
ABSTRACT
The aim of this work was to analyze the effect of estradiol [E2], medroxyprogesterone and the two selective estrogen receptor modulators [SERMs] [tamoxifen [Tam] and raloxifene [Ral]] on the estrogen receptor [ER] conformers profile performed by size exclusion HPLC in relation to hormone dependence of mammary tumors. Materials and Two types of mammary tumors were studied tumors transplanted in BALB/c mice that are medroxyprogesterone acetate [MPA]-dependent for growth, and tumors induced in Sprague-Dawley rats by intraperitoneal injection of N-nitroso-N-methylurea [NMU]. Tumors from mice treated with MPA, E2, Tam or Ral and NMU-treated rats were analyzed and compared to that of control. The tumor conformer profiles were as follows control and MPA-treated mice showed only one peak [oligomeric form]; E2-treated mice also showed only one peak [dimer]; Tam-treated mice showed one peak corresponding to a possible proteolytic fragment, and Ral-treated mice showed two peaks [oligomeric and a possible proteolytic fragment]. On the other hand, NMU-induced mammary tumors from rats showed three peaks [oligomeric, monomeric and proteolytic]. Our findings may indicate that SERMs affect the aggregation state of ER and thereby its ability to modulate genomic transcription mechanisms related to growth rate
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Assunto principal:
Tamoxifeno
/
Receptores de Estrogênio
/
Neoplasias Mamárias Animais
/
Cromatografia Líquida de Alta Pressão
/
Ratos Sprague-Dawley
/
Cloridrato de Raloxifeno
/
Estradiol
/
Neoplasias Mamárias Experimentais
/
Medroxiprogesterona
/
Camundongos
Limite:
Animais
Idioma:
Inglês
Revista:
Med. Princ. Pract.
Ano de publicação:
2004
Similares
MEDLINE
...
LILACS
LIS